Aller au contenu principal
Profil bibliographique

Fabio Brandolino

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

13Publications signalées
389Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Vasculitis and related conditionsRheumatoid Arthritis Research and TherapiesOrthopedic Infections and TreatmentsHematological disorders and diagnosticsOtitis Media and Relapsing Polychondritis

Les publications récentes

Accès ouvert 2026 review OpenAlex

Infectious disease screening in rheumatological patients: a narrative review on methods, risk stratification and clinical management

Filippo Santoro, Fabio Brandolino, Gianluigi Bajocchi, Paolo Pavone et autres

Infectious disease screening is now a routine component in the management of patients with rheumatological conditions and is mandatory in some settings before initiating biologic or conventional immunosuppressive therapies. In this narrative review, we summarize the current literature to assist clinicians in …

0 citations Figshare
Accès ouvert 2026 review OpenAlex

Infectious disease screening in rheumatological patients: a narrative review on methods, risk stratification and clinical management

Filippo Santoro, Fabio Brandolino, Gianluigi Bajocchi, Paolo Pavone et autres

Infectious disease screening is now a routine component in the management of patients with rheumatological conditions and is mandatory in some settings before initiating biologic or conventional immunosuppressive therapies. In this narrative review, we summarize the current literature to assist clinicians in …

0 citations Figshare
2026 review OpenAlex

Infectious disease screening in rheumatological patients: a narrative review on methods, risk stratification and clinical management

F. Santoro, Fabio Brandolino, Gianluigi Bajocchi, P Pavone et autres

INTRODUCTION: Infectious disease screening is now a routine component in the management of patients with rheumatological conditions and is mandatory in some settings before initiating biologic or conventional immunosuppressive therapies. AREAS COVERED: In this narrative review, we summarize the current literature to …

it (code pays fourni par la source)

0 citations Expert Review of Clinical Immunology
Accès ouvert 2025 article OpenAlex

Immunomodulatory effects of dental pulp stem cells on lymphocytes and monocytes from patients with rheumatoid arthritis

Alessandro Rossi, Giuliana Ferrari, Veronica Galli, Martina Bonacini et autres

OBJECTIVES: To investigate the immunomodulatory effects of dental pulp stem cells (DPSCs) on lymphocytes and monocytes from rheumatoid arthritis (RA) patients unresponsive to conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs). METHODS: Peripheral blood lymphocytes and monocytes were isolated from 12 RA patients unresponsive …

it (code pays fourni par la source)

1 citation Clinical and Experimental Rheumatology
Accès ouvert 2023 article OpenAlex

Pros and cons of TNF inhibitors and tocilizumab in the treatment of large vessel vasculitis

Chiara Marvisi, Caterina Ricordi, Elena Galli, Francesco Muratore et autres

Large-vessel vasculitides (LVVs) include giant cell arteritis (GCA) and Takayasu's arteritis (TAK). Even if similar, these two entities differ in terms of treatment and outcomes.High doses of glucocorticoids (GCs) are still the first choice for the treatment of both conditions. However, adjunctive …

it (code pays fourni par la source)

4 citations Clinical and Experimental Rheumatology
2022 article OpenAlex

Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs

Ludovico De Stefano, Silvia Balduzzi, Laura Bogliolo, Bernardo D’Onofrio et autres

OBJECTIVES: The safety of COVID-19 vaccination in rheumatic patients treated with biological (b) and targeted synthetic (ts) disease-modifying anti-rheumatic drugs (DMARDs) remains poorly explored. METHODS: Reactogenicity, safety and disease flares following each of the two doses of the BNT162b2 mRNA vaccine was …

it (code pays fourni par la source)

8 citations Clinical and Experimental Rheumatology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.